+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Assessment of thrombolytic affect of Reteplase in acute STEMI patients



Assessment of thrombolytic affect of Reteplase in acute STEMI patients



Journal of the Association of Physicians of India 64(1): 36-36




(PDF emailed within 1 workday: $29.90)

Accession: 057245927

Download citation: RISBibTeXText

PMID: 27727575


Related references

Platelet function in patients with acute myocardial infarction under thrombolytic therapy with reteplase, alteplase or streptokinase. Annals of Hematology 76(SUPPL 1): A33, 1998

Clinical efficacy and safety of thrombolytic treatment with reteplase in patients with intermediate-risk acute pulmonary embolism. Zhonghua Xin Xue Guan Bing Za Zhi 45(4): 314-317, 2017

Increased fibrin specificity and reduced paradoxical thrombin activation of the combined thrombolytic regimen with reteplase and abciximab versus standard reteplase thrombolysis. Drugs Under Experimental and Clinical Research 30(2): 47-54, 2004

Reteplase: A new thrombolytic for the treatment of acute myocardial infarction. Annals of Pharmacotherapy 33(3): 318-324, 1999

Reteplase. A new thrombolytic agent in the treatment of acute myocardial infarction. Ugeskrift for Laeger 160(24): 3577-3580, 1998

Platelet function during and after thrombolytic therapy for acute myocardial infarction with reteplase, alteplase, or streptokinase. Circulation 100(18): 1858-1864, 1999

Intra-arterial reteplase compared to urokinase for thrombolytic recanalization in acute ischemic stroke. Ajnr. American Journal of Neuroradiology 27(4): 769-773, 2006

Platelet function during and after thrombolytic therapy for acute myocardial infarction with reteplase, alteplase or streptokinase. Circulation 96(8 SUPPL ): I535, 10/21/97, 1997

Predictors of acute myocardial infarct size in STEMI patients receiving thrombolytic therapy: A delayed contrast enhanced cardiac MRI study. Indian Heart Journal 67(2): 122-127, 2016

The Chinese expert consensus on reteplase thrombolytic therapy for acute ST-segment elevation myocardial infarction. Zhonghua Nei Ke Za Zhi 55(7): 572-577, 2016

Additional benefits of primary PCI compared to thrombolytic therapy in acute anterior STEMI patients during long-term follow-up; the importance of left ventricular function. Circulation 108(17 Supplement): IV-466-IV-467, October 28, 2003

Efficacy of thrombolytic therapy using reteplase in cases with acute ST-segment elevation myocardial infarction: results from a multicenter clinical trial. Zhonghua Xin Xue Guan Bing Za Zhi 44(9): 766-770, 2017

Thrombolytic therapy in acute massive pulmonary embolism Double bolus reteplase versus conventional alteplase infusion in a randomized controlled trial. European Heart Journal 18(ABSTR SUPPL ): 346, 1997

Does Pantoprazole Affect the On-Treatment Platelet Reactivity in Patients With Acute STEMI Treated With ADP Receptor Blockers?-A Pilot Prospective Study. American Journal of Therapeutics 24(2): E162-E166, 2016

Reteplase plus abciximab and reteplase alone led to similar 30-day mortality rates in acute MI. Acp Journal Club 136(2): 42-43, 2002